Home > Healthcare & Medical Devices > Urinalysis Market

Urinalysis Market Size By Product (Consumables {Dipsticks, Reagents, Disposables}, Instruments {Biochemical Urine Analyzer, Automated Urine Sediment Analyzer}), By Application (Urinary Tract Infections, Kidney Diseases, Pregnancy, Diabetes), By End-use (Clinical Laboratories, Hospitals, Home Healthcare), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI439
  • Base Year: 2020
  • Report Format: PDF

Industry trends

Urinalysis Market Size exceeded USD 3 billion in 2020 and is projected to grow at a CAGR of over 5.5% from 2021 to 2027. Increasing prevalence of kidney diseases, urinary tract infections and high pregnancy rates in developing nations are some of the major factors that are expected to facilitate the market growth. Also, rising health problems among geriatric population due to weak immune system is further poised to fuel the market progression.
 

Urinalysis Market Overview

Get more details on this report - Request Free Sample PDF
 

Moreover, COVID-19 impact on the urinalysis market is observed to be significant. For instance, according to a report by National Kidney Foundation, patients hospitalized with COVID-19 are at a higher risk of developing acute kidney injury (AKI) that can lead to serious health issues including death. Therefore, the patients are recommended to visit nephrologists at regular intervals to avoid any further health complications.
 

Besides, patients who got infected with COVID-19 and did not develop symptoms of AKI but witnessed high levels of abnormal blood and/or protein in their urine were also prone to kidney problems. Furthermore, with the COVID-19 pandemic, demand and development of vaccines and therapeutic drugs and simple testing technologies has also increased that will promote the industry growth.
 

Increasing incidence of urinary tract infections in developing regions will boost the urinalysis market expansion

Rising prevalence of urinary tract infections (UTIs) in developing economies is one of the major factors that is driving the industry progression. UTIs are the most common bacterial infections that can spread to the kidneys and cause birth complications in pregnant women if remains untreated. For instance, globally it is estimated that one in two women may contract a urinary tract infection during their lifetimes and the incidence rates of UTIs are nearly 20% higher in the developing nations thus fostering the overall market demand.
 

Urinalysis is frequently used as a diagnostic method to evaluate the urinary tract infection. In addition, the urine culture helps in detecting the specific bacteria and yeast in patient’s urine that might be causing a urinary tract infection. As, urinalysis is cost effective and non-invasive method as compared to other tests, the urinalysis market revenue for urinalysis testing will continue to surge in the coming years.
 

Consumables segment will dominate the urinalysis space

The urinalysis market for consumables segment is predicted to showcase 5.4% growth rate through 2027 owing to the rising prevalence of different health disorders worldwide. Frequent usage of consumables for home testing as well as in clinics and hospitals will propel the overall industry demand.
 

For instance, urinalysis consumables such as dipsticks are one of the quickest and easiest way to test urine and detect different infections. The results are usually available in 60-120 seconds and is also known as rapid urine test, thus enhancing its demand. Several other benefits of using dipstick testing are that the sample is not required to be sent to a laboratory and it does not let a patient wait hours or days for results to arrive from laboratory. The result is available immediately, that allows clinical management to make prompt decisions. Furthermore, consumables are easily available and are cost effective screening tool that proves beneficial for the market revenue.
 

Increasing prevalence of chronic kidney diseases worldwide will fuel the market growth

Kidney diseases segment in the urinalysis market was valued at USD 690 million in 2020 led by the surging demand for urinalysis in detecting kidney diseases. In addition, globally, around 13.3 million people who suffer with acute kidney injury (AKI) each year, are also prone to CKD or kidney failure in the coming years. Thus, nephrologists suggest regular urine tests to detect the levels of albumin and creatinine present in urine, also known as albumin-creatinine ratio (ACR). This test analyses blood or protein in urine. Also, urine test results show how well kidneys are functioning and how quickly body wastes are being removed.
 

Urine dipsticks can also be used to detect the acidity in the urine. In our body, few foods, chemical imbalances, and metabolic disorders can change the acidity of urine. Change in acidity of urine can predispose the person to kidney stones. Thus, in people who are diagnosed with kidney disease, the urinalysis may be used in conjunction with other diagnostic tests to have overall diagnostic profile and decide an appropriate treatment approach.
 

Presence of skilled professionals and advanced equipment will augment the hospital segment growth

Urinalysis Market Size

Get more details on this report - Request Free Sample PDF
 

The hospital segment captured more than 38% of the urinalysis market share in 2020 impelled by the high requirement of urine tests in hospital settings. In hospitals, urinalysis is primary diagnosis performed by doctors to screen for health problems. Also, in hospitals the chances of preanalytical error of sampling, inappropriate specimen transport can be avoided.
 

Moreover, hospitals are well equipped with advanced equipment such as automated urine analyzers for accurate diagnosis along the presence of trained medical professionals. As a result, patients prefer hospitals for any type of diagnosis for better care thereby, influencing the overall industry value. Besides this, maximum number of pregnancy tests are carried out at hospital settings under the supervision of healthcare professionals with timely checkups.
 

Rising prevalence of chronic diseases in North America will accelerate the market expansion

North America Urinalysis Market

Get more details on this report - Request Free Sample PDF
 

North America urinalysis market held 36% of revenue share in 2020 on account of the increasing prevalence of chronic diseases. For instance, according to the Centers for Disease Control and Prevention (CDC) report published in 2020, more than 15% of adults in the U.S. were slated to have CKD. Another report from National Diabetes Statistics report showed that in 2020, 34.2 million i.e., 10.5% of the U.S. population had diabetes. Also, extensive R&D performed by various research laboratories, presence of major market leaders such as Abbott and Siemens and dramatic increase in public healthcare expenditure and health awareness programs in the region about routine medical checkups, will stimulate the industry revenue.
 

Presence of numerous companies will spur the market progression

Some of the prominent players operating in the urinalysis market include, Sysmex, Roche Diagnostics, Abbott, Bio-Rad Laboratories Inc., Erba Mannheim, Acon Laboratories, Cardinal Health, ARKKRAY USA Inc., HYCEL MEDICAL, Teco Diagnostics. These market participants are implementing various growth strategies to sustain the industry competition.
 

The urinalysis market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product, 2016-2027 (USD Million)

  • Consumables
    • Dipsticks
    • Reagents
    • Disposables
  • Instruments
    • Biochemical urine analyzer
    • Automated urine sediment analyzer

Market, By Application, 2016-2027 (USD Million)

  • Urinary tract infection (UTI)
  • Kidney diseases
  • Pregnancy
  • Diabetes
  • Others

Market, By End-use, 2016-2027 (USD Million)

  • Clinical laboratories
  • Hospitals
  • Home healthcare
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa

 

Authors: Sumant Ugalmugale, Rupali Swain

Frequently Asked Questions (FAQ) :

Market size of urinalysis surpassed USD 3 billion in 2020 and will exhibit a CAGR of more than 5.5% between 2021 and 2027 with rising cases of kidney diseases and urinary tract infections.

Consumables could observe a CAGR of 5.4% by 2027 on account of immediate results, easy availability, and cost-effective screening tool.

Hospitals accounted for over 38% of the market share in 2020 and will grow due to the availability of advanced equipment.

North America market garnered around 36% of revenue share in 2020 and could witness an upward growth with the presence of leading companies, research laboratories, and a rising healthcare budget.

Erba Mannheim, ARKKRAY USA Inc., Teco Diagnostics, Abbott, Sysmex and Acon Laboratories, among others are a few of the major companies underpinning market outlook.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Published Date: Nov 2021
  • Companies covered: 10
  • Tables & Figures: 156
  • Countries covered: 18
  • Pages: 200

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount